Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy

MLA

Xavier M. Teitsma, et al. “Identification of Differential Co-Expressed Gene Networks in Early Rheumatoid Arthritis Achieving Sustained Drug-Free Remission after Treatment with a Tocilizumab-Based or Methotrexate-Based Strategy.” Arthritis Research & Therapy, vol. 19, no. 1, July 2017, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13075-017-1378-x.

APA

Xavier M. Teitsma, Johannes W. G. Jacobs, Michal Mokry, Michelle E. A. Borm, Attila Pethö-Schramm, Jacob M. van Laar, Johannes W. J. Bijlsma, & Floris P. J. Lafeber. (2017). Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy. Arthritis Research & Therapy, 19(1), 1–10. https://doi.org/10.1186/s13075-017-1378-x

Chicago

Xavier M. Teitsma, Johannes W. G. Jacobs, Michal Mokry, Michelle E. A. Borm, Attila Pethö-Schramm, Jacob M. van Laar, Johannes W. J. Bijlsma, and Floris P. J. Lafeber. 2017. “Identification of Differential Co-Expressed Gene Networks in Early Rheumatoid Arthritis Achieving Sustained Drug-Free Remission after Treatment with a Tocilizumab-Based or Methotrexate-Based Strategy.” Arthritis Research & Therapy 19 (1): 1–10. doi:10.1186/s13075-017-1378-x.